Literature DB >> 10190524

Arrhythmia and survival in patients >18 years of age after the mustard procedure for complete transposition of the great arteries.

G Puley1, S Siu, M Connelly, D Harrison, G Webb, W G Williams, L Harris.   

Abstract

Increasing numbers of patients who underwent Mustard repair as children are now adults. Loss of sinus rhythm, supraventricular arrhythmias, and sudden death have been described in pediatric series. However, little is known about the clinical course of adult patients. This retrospective cohort study examined 86 consecutive adults (age >18 years) who had undergone the Mustard procedure and were referred to an adult congenital cardiac clinic for ongoing follow-up. The incidence and predictors of arrhythmia, congestive heart failure, and death were determined. The median follow-up period was 8 years after age 18 or 23 years after Mustard repair. There were 8 deaths (9%), 2 were sudden. Congestive heart failure (CHF) requiring hospital admission occurred in 9 patients (10%). Pulmonary hypertension and systemic ventricular dysfunction were independent risk factors for death or CHF. Only 29 patients (34%) remained arrhythmia-free. Forty-one patients (48%) had at least 1 episode of supraventricular tachycardia (SVT), with most patients (30, 73%) having atrial flutter. SVT after the age of 18 was associated with CHF. Pulmonary hypertension, systemic ventricular dysfunction, and junctional rhythm before age 18 were independent risk factors for SVT. Pacemakers were implanted in 19 patients (22%); 13 of those were beyond age 18. Thus, adult survivors of the Mustard procedure continue to be at risk for premature death, CHF and supraventricular tachyarrhythmia.

Entities:  

Mesh:

Year:  1999        PMID: 10190524     DOI: 10.1016/s0002-9149(99)00019-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Successful management of isolated ventricular inversion in an adult.

Authors:  B R J Kannan; K P Kamath; S G Rao; R K Kumar
Journal:  Pediatr Cardiol       Date:  2004-05-20       Impact factor: 1.655

Review 2.  Sudden cardiac death and malignant arrhythmias: the scope of the problem in adult congenital heart patients.

Authors:  James C Perry
Journal:  Pediatr Cardiol       Date:  2012-02-09       Impact factor: 1.655

3.  Exercise capacity in adult patients with congenitally corrected transposition of the great arteries.

Authors:  P M Fredriksen; A Chen; G Veldtman; S Hechter; J Therrien; G Webb
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 4.  Management of Heart Failure in Adult Congenital Heart Disease.

Authors:  Aarthi Sabanayagam; Omer Cavus; Jordan Williams; Elisa Bradley
Journal:  Heart Fail Clin       Date:  2018-08-20       Impact factor: 3.179

Review 5.  Monitoring the patient with transposition of the great arteries: arterial switch versus atrial switch.

Authors:  Susan Lucy Roche; Candice Kristine Silversides; Erwin Notker Oechslin
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

Review 6.  Burden of Heart Failure in Adults with Congenital Heart Disease.

Authors:  Laith I Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Heart Fail Rep       Date:  2016-10

7.  Superior vena cava stenting and transvenous pacemaker implantation (stent and pace) after the Mustard operation.

Authors:  Mathias Emmel; Narayanswami Sreeram; Konrad Brockmeier; Gerardus Bennink
Journal:  Clin Res Cardiol       Date:  2006-10-30       Impact factor: 5.460

8.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.

Authors:  Candice K Silversides; Omid Salehian; Erwin Oechslin; Markus Schwerzmann; Isabelle Vonder Muhll; Paul Khairy; Eric Horlick; Mike Landzberg; Folkert Meijboom; Carole Warnes; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

9.  Patient-activated antitachycardia pacing to terminate atrial tachycardias with 1:1 atrioventricular conduction in congenital heart disease.

Authors:  Anjan S Batra
Journal:  Pediatr Cardiol       Date:  2007-12-25       Impact factor: 1.655

10.  Device therapy to prevent sudden death in patients with structural heart disease.

Authors:  N Sreeram; U Trieschmann; M Emmel; M Khalil
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.